ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,048.42
-0.46%
US Tech 100
17,168.35
0.63%
Dow Jones
38,085.80
-0.98%
Brent Oil
88.255
0.12%
Bitcoin
64,426.09
-0.09%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Pharvaris NV (PHVS) Quote

Pharvaris NV

Pharvaris NV (PHVS)

NASDAQ
22.77
1.52
(7.15%)
Closed April 25 4:00PM
Delayed by 15 minutes
22.77
0.00
(0.00%)
After Hours: 5:30PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
22.77
Bid
20.50
Ask
36.06
Volume
82,367
19.59 Day's Range 24.00
7.93 52 Week Range 33.00
Market Cap
931.171M
Previous Close
21.25
Open
20.74
Last Trade
260
@
22.77
(formt)
Last Trade Time
Financial Volume
$ 1,794,489
VWAP
21.7865
Average Volume (3m)
91,935
Shares Outstanding
40,822,916
Dividend Yield
-
PE Ratio
-9.23
Earnings Per Share (EPS)
-2.47
Revenue
-
Net Profit
-100.88M

About Pharvaris NV

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.pharvaris.com
Headquarters
Leiden, South Holland, Nld
Founded
1970
Pharvaris NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PHVS. The last closing price for Pharvaris NV was $21.25. Over the last year, Pharvaris NV shares have traded in a share price range of $ 7.93 to $ 33.00.

Pharvaris NV currently has 40,822,916 shares outstanding. The market capitalization of Pharvaris NV is $931.17 million. Pharvaris NV has a price to earnings ratio (PE ratio) of -9.23.

PHVS Latest News

More News

Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

RAPIDe-3, a global pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, is currently enrollingEnd-of-Phase 2 meeting scheduled to discuss development plan of...

April 10 2024
GlobeNewswire Inc.

Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer

ZUG, Switzerland, April 10, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to treat and...

April 10 2024
GlobeNewswire Inc.

Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference

ZUG, Switzerland, April 04, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to treat and...

April 04 2024
GlobeNewswire Inc.

Pharvaris Announces Phase 3 Clinical Study Design for Recently Initiated RAPIDe-3 Study, and Presents Quality-of-Life Improvement and Caregiver Behavior Data at Two Recent HAE Congresses

The company announced the initiation of RAPIDe-3, the Phase 3 clinical trial evaluating the efficacy and safety of deucrictibant immediate-release capsule (PHVS416) for the treatment of HAE...

March 18 2024
GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities

March 11 2024
Edgar (US Regulatory)

Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

March 06 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

March 06 2024
Edgar (US Regulatory)

Pharvaris to Present Deucrictibant Clinical Data at Upcoming Congresses

ZUG, Switzerland, March 06, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary...

March 06 2024
GlobeNewswire Inc.

Pharvaris to Participate in the Leerink Global Biopharma Conference 2024

ZUG, Switzerland, March 05, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary...

March 05 2024
GlobeNewswire Inc.

Positive Results from CHAPTER-1 Phase 2 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks to be Presented at AAAAI 2024 Annual Meeting

ZUG, Switzerland, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary...

February 22 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.587.4563473336521.1924.217.577536319.94446151CS
4-0.43-1.8534482758623.225.1917.577862021.18567477CS
12-7.04-23.616236162429.813317.579193525.17313234CS
264.4524.290393013118.32331512020325.07397637CS
5213.8153.8461538468.97337.938193222.88637467CS
156-3.31-12.691717791426.08331.7719100412.60546689CS
260-2.23-8.922542.861.7718688013.45606125CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ISUNiSun Inc
$ 0.173
(84.04%)
19.93M
BRFHBarfresh Food Group Inc
$ 1.75
(69.90%)
44.33M
SGBXSafe and Green Holdings Corporation
$ 0.225
(56.14%)
136.91M
PCSAProcessa Pharmaceuticals Inc
$ 2.4137
(48.99%)
77.21M
BACKIMAC Holdings Inc
$ 5.065
(45.34%)
8.49M
EJHE Home Household Service Holdings Ltd
$ 0.767
(-73.64%)
12.36M
TVGNTevogen Bio Holdings Inc
$ 0.9057
(-39.62%)
328.69k
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.265
(-37.69%)
16.75M
ATNIATN International Inc
$ 19.24
(-33.01%)
440.2k
BNAIBrand Engagement Network Inc
$ 2.59
(-30.56%)
234.29k
SQQQProShares UltraPro Short QQQ
$ 12.00
(1.61%)
167.48M
SGBXSafe and Green Holdings Corporation
$ 0.225
(56.14%)
136.91M
TSLATesla Inc
$ 170.18
(4.97%)
126.42M
ACONAclarion Inc
$ 0.383149
(33.04%)
115.53M
TQQQProShares UltraPro QQQ
$ 52.85
(-1.60%)
86.41M

PHVS Discussion

View Posts
Monksdream Monksdream 3 months ago
PHVS new 52 week low
👍️0
europtiger europtiger 9 months ago
Haven’t been here in a while… but this one is just a sweet long position. Soon to be 20+ imho
👍️0
subslover subslover 1 year ago
Excellent call on the $12,00's. I just confirmed today's 12,24 is the 52-week high! :)
👍️0
europtiger europtiger 1 year ago
Yeah looking great… my average now ist even 8,30 as I bought 2 more k when she was in the 7,s so I got lucky. Let’s see, hoping for 12 break soon here

Good luck to you
👍️0
subslover subslover 1 year ago
Your doing great closed $11.20 :)
👍️0
europtiger europtiger 1 year ago
So I got now average 8,80$

Let’s see I guess
👍️0
Pt3 Pt3 1 year ago
What going on back to 7
👍️0
winna winna 1 year ago
???
👍️0
MT101 MT101 1 year ago
Ez hold. Down 12% and you think it’s bearish after a 400% run hahahahah loaded more today too.
👍️0
winna winna 1 year ago
You were saying?
👍️0
Invest-in-America Invest-in-America 1 year ago
PHVS: "RED prices at morning, sailors take warning!!" (Well, something like that.)



👍️0
Invest-in-America Invest-in-America 1 year ago
PHVS:: Were you referring to YOURSELF, Sir, with that post????? (See today's PHVS chart, below.)

👍️0
Invest-in-America Invest-in-America 1 year ago
PHVS: Where have all the smart-ass, know-it-all's gone??????? (Can't even discern conspicuous FLUFF PR's when ya see 'em!!!)

👍️0
Invest-in-America Invest-in-America 1 year ago
PHVS: The RED PRICE will edify you today --- so, ignore me if you like. Bottom line, Sir, you need a REMEDIAL course in how IGNORANT this primitive Planet is in the area of Human THERAPEUTIC Medical (so-called) "SCIENCE".
👍️0
MT101 MT101 1 year ago
I actually just loaded every more in PM. This is going to explode at open most likely another 300-400% day. Your screwed dude you should have covered yesterday!
👍️0
Invest-in-America Invest-in-America 1 year ago
It is going NOWHERE, Dude. It had its run; it's DONE Hope you didn't hold any overnight.
👍️0
MT101 MT101 1 year ago
Everything your saying is false. I sure hope your joking about being a short, your going to get toasted to a crisp today if you are.. this things about to go parabolic. Monday will probably blow up too. Easily $40+ here
👍️0
MT101 MT101 1 year ago
Shorts are trapped this is HKD 2.0
👍️0
Invest-in-America Invest-in-America 1 year ago
PHVS: It was a monster runner, that's for sure. GOOD LUCK today, however. (Pure FLUFF news, if there ever was any anywhere.)
👍️0
Invest-in-America Invest-in-America 1 year ago
PHVS: I do NOT own any of this. And, if I ran Wall Street, SHORTING any stock would be prohibited by LAW. WHY?? Because such practice is betting on a Company to LOSE value. Bottom line, SHORTING stocks is yet another example of the CORRUPT nature of American Commerce, Industry, & Government at its CORE. Similar to how in America, just ONE GUY/GAL can win a ONE-BILLION-DOLLAR lottery all for their SELFISH SELVES!!!
👍️0
MT101 MT101 1 year ago
Lol your going to lose your entire portfolio trying to short this one. Please be my guest! Love seeing shorts get their asses burned!
👍️0
MT101 MT101 1 year ago
They will try but the buying pressure is way to aggressive right now and short shares are hard to find, I checked multiple platforms. Shorts that are holding there position overnight are going to get wrecked af tomorrow
👍️0
doebop doebop 1 year ago
Agree best to wait for pop tomorrow then short if you can borrow
👍️0
Laster Laster 1 year ago
Actually Hereditary Angioedema is very hard to treat. Different than ACE induced angioedema. News looks promising but it is phase 2 data. The bigger concern is that the FDA halted their US trials on August for some reason. Therefore, the company is only doing trials outside the US.

Stock dropped $2 after hours. Let’s see how it trades Premarket.

I almost got into this at $4.70 just around noon but the stock immediately exploded to $5.80. Never seen anything like that. I saw that it was a market buy order of about 150,000 shares. Wow.
👍️0
Pt3 Pt3 1 year ago
Short can't short cuz this going to 20-30
👍️0
winna winna 1 year ago
They will short this down tomorrow
👍️0
MT101 MT101 1 year ago
Dude your so screwed if you don’t cover before tomorrow open. It’s going to $20-40
👍️0
Invest-in-America Invest-in-America 1 year ago
Watch out for RED INK tomorrow, behind this FLUFF-NEWS crap!!!
👍️0
Invest-in-America Invest-in-America 1 year ago
PHVS: My post is the TRUTH, Dude; if you can't recognize pure FLUFF Medical "NEWS" --- & about an extremely RARE disease, to boot --- well then, nobody can help you, Sir. (GOOD LUCK!!!)
👍️0
MT101 MT101 1 year ago
False. I recommend you cover your short or get burned out. This is going to $20-40 tomorrow. Tik Tok Tik Tok your running out of time.
👍️0
Invest-in-America Invest-in-America 1 year ago
PHVS: Price SOARED today, & all behind the most FLUFF news of this calendar year so far!! (Maybe of this ENTIRE year, moving forward; a firm that is LOSING money every year, & barely past the "Proof Of Concept" stage for yet ANOTHER purported treatment for whatever.)
👍️0
MT101 MT101 1 year ago
That’s good. I loaded 3k shares here around $10 range. I think this is going to $20-40 possibly. Massive news
👍️0
europtiger europtiger 1 year ago
Got me 2,5 k shares just now below 10$

Could see a nice buy out offer at some stage
👍️0
MT101 MT101 1 year ago
Going to $20-30 range
👍️0
subslover subslover 1 year ago
This stock has sure gone crazy! LMAO all the way to Wells Fargo!
👍️0
Invest-in-America Invest-in-America 1 year ago
PHVS: Indeed!!! NOT even that, per se --- really just "Proof of Concept"!! What a JOKE!! Hey, Dude, Wall Street is a GAMBLING CASINO. ANY stupid stock can SOAR; if some TRENDING/INFLUENTIAL folks or entities are pumping it, that is.

This little PUMPED PUPPY might just Close today at circa 900% UP!!!
👍️0
subslover subslover 1 year ago
HALTED for the 3rd time at 1;30 PM @ $11.93
👍️0
subslover subslover 1 year ago
$10.00 just breached.
👍️0
winna winna 1 year ago
They will short this big time
👍️0
Cosa Cosa 1 year ago
This big move is from phase 2 results?
👍️0
subslover subslover 1 year ago
Trading resumed at 12:30 pm @ $7.50. What a wild ride this turned out to be!
👍️0
davidsson10 davidsson10 1 year ago
Yes, that'll work.....
👍️0
subslover subslover 1 year ago
HALTED again 12;28pm @ $8.18
👍️0
subslover subslover 1 year ago
Trading resumed at 12:17pm @ $7.00
👍️0
subslover subslover 1 year ago
HALTED at noon @ $5.78
👍️0
subslover subslover 1 year ago
Pharvaris Reports Third Quarter 2022 Financial Results and Provides Business Update


https://www.otcmarkets.com/stock/PHVS/news/story?e&id=2400295
👍️0
subslover subslover 1 year ago
Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks
https://www.otcmarkets.com/stock/PHVS/news/story?e&id=2400291
👍️0

Your Recent History

NASDAQ
PHVS
Pharvaris NV
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved